Navigation Links
mini VIDAS

Productsmini VIDAS
Company Summit Lab Sales
Item mini VIDAS
Features 
  • Reliable and economic
  • Uses ELFA (Enzyme linked fluorescent assay) technology
  • No carryover risks
  • Requires only a one-point recalibration every 14 days
  • Optimizes the cost per patient for a batch of single sample testing
  • Multiparametric analyzer
  • Simple and rapid
  • Maintenance is minimal
  • Most results are available in 30 minutes
Description The Mini Vidas is a compact version of the Vidas system with a built-in computer, keyboard and printer. Two independent sections each accept six tests and can process up to 12 samples simultaneously.
Info Summit Lab Sales
Customer Service: 1-888-445-8492
Web site: http://SummitLabSales.com

Related medicine products :

1. VIDAS
2. VIDAS Clostridium difficile (Toxin A) assay
3. mini VIDAS - Recertified
TAG: mini VIDAS
...uptures are problem enough for your patients. Now ...unctional treatment for foot and ankle fractures a...TORM. A combination of prefabricated brace and ope...nt with higher standards of safety. The storm can ...
The Active Ankle Trainer model provides medial/lateral support and optimum ankle mobility for chronic and prophylactic use.
The Bledsoe M-Brace Ankle Support reduces ankle swelling while boosting the patient's confidence when its time to get back in the game. The M-Brace is available in two models the Air M-Brace or the
The Bledsoe ST & ST2 Boots are low-cost, lightweight walkers for short term applications. The ST & ST2 are designed to enhance mobility for sprains, strains, and some types of fractures. The Bledsoe
Medicine Products:
(Date:11/22/2008)...Altering recipes to cut fat, salt a quick fix with...AY, Nov. 22 (HealthDay News) -- You can eat health...king good food choices, say experts with the Texas...an reduce the sugar, fat or salt content of almost...e in taste, nutrition specialist Mary Bielamowicz ...
(Date:11/21/2008)...Kids, parents and schools need to work together to...FRIDAY, Nov. 21 (HealthDay News) -- Behavior that ...ognized as bullying. , And as mounting research...the victim, mental-health professionals, schools, ...h new ways to combat this threatening behavior. ,...
(Date:11/21/2008)...LOVELAND, Colo., Nov. 21 ...ced it will present at the New York Society of,Se... Pharma Conference on,December 2, 2008 at 1177 Av...The presentation is scheduled to begin at 9:35 a.m... be available via live webcast and for two weeks,...
(Date:11/21/2008)...Finding might one day lead to a novel technique to...Y, Nov. 21 (HealthDay News) -- Belgian researchers... acid instead of sugar for food, and this might le...lls. , To survive and proliferate, all cells in...burning sugar [glucose], a process that requires o...
Breaking Medicine News(10 mins):Health News:Substitutions Make Holiday Fare Healthier 2Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3Health News:New Approach Keeps Tumor Cells From Refueling 2
...s to have struck the honeybee population across th...nty two states have been affected by this weird ai...bee keepers and honey production. Bee keepers hav...heir bee population. Sometime back, a parasite cal...
... of nanoparticle that could be used in tests for e... products, as well as for medical diagnosis. The r... Nanotechnology. Nanoparticles, according to Ian ...mechanical and aeronautical engineering and senior...
...tly increases a woman’s risk of becoming infected ...March 1st edition of The Journal of Infectious Dis...at several sexually transmitted infections increas...on of HIV. Although there are 173 million cases of...
...ave found a set of "master switches" that keep adu...te//. Unlocking the switches' code may one day ena...ant into patients with cancer and other bone marro...e control switches not at the gene level, but fart...
Other Medicine News:Health News:UC Davis Creates New Nanoparticles 2Health News:Vaginalis Increases the Risk of Becoming Infected With HIV 2Health News:Vaginalis Increases the Risk of Becoming Infected With HIV 3Health News:Master Switches Found for Adult Blood Stem Cells 2
(Date:11/20/2008)...f., Nov. 20 Epeius Biotechnologies... studies of Rexin-G in,chemotherapy-resistant met...presented by Dr. Sant P. Chawla, principal investi...ondon UK on November 13-15, 2008. Patients receive...d up to 9 months. Analysis of,safety and efficacy...
(Date:11/20/2008)...., Nov. 20 New Jersey American Wat...ory for its customers in the following municipalit... , Middlesex County , , , Dune...iscataway , South Plainfield , , ,...d Brook , Bridgewater , Green Brook ...
(Date:11/20/2008)...TOP LINE RESULTS OF FIRST PHASE III TRIAL SHOW SIG...IMPROVEMENT IN DAILY FUNCTION, IN, ...O, Calif., and BRUSSELS, Belgium, Nov. 20 /PRNewsw...daq: JAZZ ) and UCB (Euronext Brussels: UCB),an...s from the first of two,Phase III pivotal clinica...
(Date:11/20/2008)...., Nov. 20 Milk. It does a body go...ally thought. After years of,research, scientists...nd in,cow,s milk that stimulate the body,s own pr... Multimedia News Release, go to:, http://www.prnew...le developing new cancer therapies, the chief scie...
Breaking Medicine Technology:Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2New Research on Genetic Changes in Melanomas and Teens Use of Indoor Tanning Could Lead to Better Prevention and Treatment Strategies 24662 1New Research on Genetic Changes in Melanomas and Teens Use of Indoor Tanning Could Lead to Better Prevention and Treatment Strategies 24662 2New Research on Genetic Changes in Melanomas and Teens Use of Indoor Tanning Could Lead to Better Prevention and Treatment Strategies 24662 3New Research on Genetic Changes in Melanomas and Teens Use of Indoor Tanning Could Lead to Better Prevention and Treatment Strategies 24662 4Back to School Resolution 3A Practice Food Safety and Healthier Eating 24656 1Back to School Resolution 3A Practice Food Safety and Healthier Eating 24656 2J P McCarthy Fund Grants 24250 000 to Karmanos Cancer Institute 24653 1J P McCarthy Fund Grants 24250 000 to Karmanos Cancer Institute 24653 2J P McCarthy Fund Grants 24250 000 to Karmanos Cancer Institute 24653 3J P McCarthy Fund Grants 24250 000 to Karmanos Cancer Institute 24653 4Possible Cause of Postpartum Depression Pinpointed 24649 1Possible Cause of Postpartum Depression Pinpointed 24649 2Possible Cause of Postpartum Depression Pinpointed 24649 3
...tivity and patient tolerance observed in Genotype,...ontinuous,delivery therapy, WASHINGTON, May 21, 20...privately held biopharmaceutical company, today an...hase 2 study comparing,the combination of injectab...ron alone in treatment-naive patients with genotyp...
...ESS WIRE)--May 21, 2007 - Results from a new,study...eek (DDW),conference, showed that more than 99 per...CV) infection who were treated,successfully with P...e virus up to seven years later - validating the u... according to study,authors. Currently, the best i...
Other Medicine Technology:Intarcia Therapeutics Announces Presentation of Final Results From,a Phase 2 Combination Study for the Treatment of Hepatitis C at the,Digestive Disease Week Conference 2Intarcia Therapeutics Announces Presentation of Final Results From,a Phase 2 Combination Study for the Treatment of Hepatitis C at the,Digestive Disease Week Conference 3Intarcia Therapeutics Announces Presentation of Final Results From,a Phase 2 Combination Study for the Treatment of Hepatitis C at the,Digestive Disease Week Conference 4Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 2Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 3Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 4Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 5Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 6